A Certified Reference Material
Features
  • This product is qualified as a Certified Reference Material (CRM) that has been manufactured and tested to meet ISO/IEC 17025 and ISO 17034 international standards
  • This CRM has been characterized by metrologically valid procedures and may be used as a quantitative analytical reference standard
  • Certificate of analysis provides the certified property values and the associated uncertainties, including a statement of metrological traceability for the certified values
  • Possession of a DEA Controlled Substance registration is not necessary nor is a DEA 222 form required to purchase this product
  • Bulk material is available for qualified institutions; please contact our sales department for pricing
Related Products
Alternative(s)
34780Psilocin-d6
Analytical Standard(s)
31734Psilocin-d10
Unlabeled Version(s)
11864Psilocin 9003135Psilocin (CRM) 36971Psilocin (hemifumarate)
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Psilocin-d10 (CRM)

A 100 μg/ml solution in acetonitrile

Item No. 37038

Exempt Product (US)
Safety Data Sheet (SDS) (PDF)
Synonyms
Synonyms
  • 4-hydroxy-N,N-Dimethyltryptamine-d10
  • 4-hydroxy DMT-d10
Technical Information
Formal Name
3-[2-[di(methyl-d3)amino]ethyl-1,1,2,2-d4]-1H-Indol-4-ol
CAS Number
1435934-64-7
Molecular Formula
C12H6D10N2O
Formula Weight
214.3
Formulation
A 100 μg/ml solution in acetonitrile
SMILES
OC1=CC=CC2=C1C(C([2H])([2H])C([2H])([2H])N(C([2H])([2H])[2H])C([2H])([2H])[2H])=CN2
InChi Code
InChI=1S/C12H16N2O/c1-14(2)7-6-9-8-13-10-4-3-5-11(15)12(9)10/h3-5,8,13,15H,6-7H2,1-2H3/i1D3,2D3,6D2,7D2
InChi Key
SPCIYGNTAMCTRO-HXOHQZFQSA-N
Regulatory Information
DEA Exempt Notification
This product is a DEA exempt preparation of a scheduled compound - does not require DEA Controlled Substance registration or DEA 222 form. For alternate sizes please contact sales.
Shipping & Storage Information
Storage
-20°C
Shipping
Dry ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    100 µg

    $167

    Add
    Cayman Chemical
    Forensic Lab Guide Wall Posters

    Discover our collection of drug identification, naming, and metabolism posters for your lab. We offer all of our posters at no cost to help support the forensic community.

    REQUEST YOURS
    Product Description

    Psilocin-d10 (CRM) (Item No. 37038) is a certified reference material intended for use as an internal standard for the quantification of psilocin (Item Nos. 9003135 | 11864 | 36971) by GC- or LC-MS. Psilocin is categorized as a tryptamine.1 Psilocin is the active metabolite of the psychedelic compound psilocybin (Item Nos. 9003134 | 14041) and the synthetic tryptamine 4-acetoxy DMT (psilacetin; Item Nos. 14056 | 35188).2,3 It induces the head-twitch response (HTR) in mice, indicating hallucinogenic potential.4 Psilocin-d10 is regulated as a Schedule I compound in the United States. Psilocin-d10 (CRM) (Item No. 37038) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Blair, J.B., Kurrasch-Orbaugh, D., Marona-Lewicka, D., et al. Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines. J. Med. Chem. 43(24), 4701-4710 (2000).

    2. Halberstadt, A.L., Koedood, L., Powell, S.B., et al. Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice. J. Psychopharmacol. 25(11), 1548-1561 (2011).

    3. Geiger, H.A., Wurst, M.G., and Daniels, R.N. DARK classics in chemical neuroscience: Psilocybin. ACS Chem. Neurosci. 9(10), 2438-2447 (2018).

    4. Glatfelter, G.C., Pottie, E., Partilla, J.S., et al. Structure–activity relationships for psilocybin, baeocystin, aeruginascin, and related analogues to produce pharmacological effects in mice. ACS Pharmacol. Transl. Sci. 5(11), 1181-1196 (2022).